"Priority is given to the recommendation of vaccines with sequential booster immunization, or containing or having good cross immunity to Omicron virus strains." On December 14, at the joint prevention and control conference of the State Council, Xia Gang, Director of the Department of Health and Immunization of the National Bureau of Disease Control and Prevention, introduced that, according to the vaccination strategy, all 13 vaccines approved for conditional marketing or emergency use can be used for the second booster immunization. From the perspective of prevention, the second booster immunization is the fourth dose of COVID-19 vaccine for most people. How can we better respond to the infection of Omikjon mutant? From the perspective of treatment, the demand of people for post COVID-19 treatment drugs has increased significantly. Is the production capacity sufficient? The participating experts responded one by one. It is suggested that the key population should be actively vaccinated with the fourth dose introduced by Xia Gang. Under the severe and complex epidemic prevention and control situation at this stage, the elderly and other high-risk groups continue to face the risk of infection. Therefore, the joint prevention and control mechanism of the State Council has recently made further adjustments and improvements to the vaccination strategy of COVID-19. The high-risk population, the elderly over 60 years old, the population with more serious basic diseases and the population with low immunity can receive the second dose of booster immunization six months after completing the first dose of booster immunization. According to reports, the National Health Commission is guiding local organizations to implement relevant work. Specific vaccination arrangements are based on local specific work. Eligible people can actively vaccinate, take the initiative to vaccinate, and vaccinate as soon as possible. The drug production capacity of COVID-19 is sufficient "the drug production capacity of COVID-19 in China can meet the drug demand of patients" Zhou Jian, Deputy Director of the Consumer Products Industry Department of the Ministry of Industry and Information Technology, said frankly that the number of patients has increased recently, the demand for drugs has surged, and there is a shortage in some places and some varieties. At present, the Ministry of Industry and Information Technology and other departments have promoted enterprises to achieve stable production, expand capacity and expand production rapidly, increase the supply of key drugs in the market, guide rational, orderly and accurate delivery, and strive to alleviate the problem of drug purchase. It is reported that the Ministry of Industry and Information Technology has included relevant production enterprises and key supporting enterprises in the "white list" management for the relevant drugs mentioned in the "Diagnosis and Treatment Plan for novel coronavirus Pneumonia (Ninth Edition)" and the "Guidelines for Chinese Medicine Intervention at Home for COVID-19 Infected Persons", to support enterprises to quickly enter the full load production state. At the same time, we will help enterprises to formulate a plan for increasing production and capacity through "one medicine, one policy". We will tap into existing production capacity and increase product output through technological transformation, new production lines and entrusted production. At the same time, accurate delivery is organized, for example, large online pharmacies are organized to develop online drug purchase platforms for patients, and drugs can be delivered to patients in a timely manner by means of real name authentication, uploading antigen test certificates, etc. Make good use of the "New Ten Rules" of the docking mechanism between communities and specialized medical institutions, promote the establishment of the docking mechanism between communities and specialized medical institutions, and provide medical convenience for the elderly living alone, minors, pregnant and lying in women, the disabled, and patients with chronic diseases. Is this passage unobstructed? Gao Guangming, Deputy Director of the Medical Emergency Department of the National Health Commission, said that in the process of deepening medical reform, China's medical system has been actively promoting urban medical associations and county medical communities, and strengthening the communication, coordination and interaction of medical resources. At present, in the three-level medical service system, the upper and lower referral channels are